Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tevogen Bio Holdings Inc. - Common Stock
(NQ:
TVGN
)
0.5219
+0.0242 (+4.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tevogen Bio Holdings Inc. - Common Stock
< Previous
1
2
3
Next >
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via
Benzinga
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
August 22, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
August 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
August 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health
August 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities
August 09, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
July 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
July 10, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities
June 26, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility
July 08, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances
June 25, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference
June 18, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Set to Join Russell 3000® Index
June 12, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 12, 2024
Via
Benzinga
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
June 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event
June 07, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event
June 06, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2
June 06, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
TVGN Stock Earnings: Tevogen Bio Holdings Reported Results for Q1 2024
May 30, 2024
Tevogen Bio Holdings just reported results for the first quarter of 2024.
Via
InvestorPlace
Tevogen Bio Reports First Quarter 2024 Financial Results
May 29, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
May 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 21, 2024
Via
Benzinga
Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
May 16, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 13, 2024
Via
Benzinga
Why Tevogen Bio Holdings Stock Is Moving Higher Today
May 13, 2024
Tevogen shares are rising Monday after the company secured up to $50 million of financing from an existing investor aimed at supporting continued research and development efforts for Tevogen's TVGN...
Via
Benzinga
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
May 13, 2024
TransCode Therapeutics stock is down on Monday after the company announced plans for a shareholder meeting for RNAZ investors.
Via
InvestorPlace
Why Is Safe & Green Development (SGD) Stock Down 5% Today?
May 13, 2024
Safe & Green Development stock is down on Monday as SGD investors learn of a Form D filing with the SEC for a securities sale.
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Is AC Immune (ACIU) Stock Up 45% Today?
May 13, 2024
AC Immune stock is up on Monday after as investors in ACIU react to a new collaboration agreement with Takeda Pharmaceutical.
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.